Arkolith/Insider Trading/BFRI/Form 4

Luebbert Hermann

CEO & Chairman, DirectorBiofrontera Inc. (BFRI) · full profile →Form 4 · filed Sep 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2025Option exercise(M)138K——153K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2025Option exercise(M)138K—$0138K
Jul 22, 2025Grant(A)125K—$0125K
Jul 22, 2025Grant(A)125K—$0125K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-013799) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML